Results 91 to 100 of about 12,007 (200)

Return to baseline arsenic concentrations after 1 year on gluten‐free diet in children with celiac disease: A prospective cohort study

open access: yesJPGN Reports, Volume 7, Issue 2, Page 315-322, May 2026.
Abstract Objectives Lifelong adherence to a gluten‐free diet (GFD) is the primary treatment for celiac disease (CeD). Concerns have been raised about increased exposure to contaminants in a GFD because rice, which naturally bioaccumulates arsenic and other environmental contaminants, is commonly used as a substitute for gluten.
Nan Du   +4 more
wiley   +1 more source

The Two Faces of Wheat

open access: yesFrontiers in Nutrition, 2020
Wheat-based foods have been staple foods since about 10,000 years and constitute a major source of energy, dietary fiber, and micronutrients for the world population.
Herbert Wieser   +2 more
doaj   +1 more source

Hypoglycemia Occurrence and Risk Factors in Insulin Independent Patients After Total Pancreatectomy With Islet Autotransplantation

open access: yesClinical Transplantation, Volume 40, Issue 5, May 2026.
ABSTRACT Background Total pancreatectomy with islet auto‐transplantation (TPIAT) alleviates pain and preserves islet function in patients with severe pancreatitis. Although approximately one third of recipients achieve insulin independence, spontaneous hypoglycemia has been observed in this population. Its frequency, risk factors, and management remain
Azza Hassaan   +10 more
wiley   +1 more source

Fecal Gluten Peptides Reveal Limitations of Serological Tests and Food Questionnaires for Monitoring Gluten-Free Diet in Celiac Disease Patients [PDF]

open access: yes, 2016
Objectives: Treatment for celiac disease (CD) is a lifelong strict gluten-free diet (GFD). Patients should be followed-up with dietary interviews and serology as CD markers to ensure adherence to the diet.
Comino Montilla, Isabel María   +5 more
core   +1 more source

GLUTEN-SENSITIVE ENTEROPATHY IN CHILDREN: STATE OF THE PROBLEM ON MODERN STAGE

open access: yesUkrainian Scientific Medical Youth Journal, 2015
The article is dedicated to problems of gluten-sensitive enteropathy (celiac disease) appearing nowadays on modern stage of pediatric science development.
А.А. Horobets
doaj  

Microbial Peptidases: Key Players in Reducing Gluten Immunogenicity Through Peptide Degradation

open access: yesApplied Sciences
Gluten-related disorders, including celiac disease (CeD) and non-celiac gluten sensitivity (NCGS), are triggered by the immune response to gluten peptides that resist complete digestion by human gastrointestinal enzymes. Microbial peptidases have emerged
Africa Sanchiz   +6 more
doaj   +1 more source

Integrating Human Intestinal Organoids into FDA's New Approach Methodologies for Drug Discovery

open access: yesAdvanced Science, Volume 13, Issue 20, 9 April 2026.
Illustration summarizes how human intestinal organoids (HIOs) are becoming transformative in preclinical research. Preclinical drug discovery pipelines often rely on animal models for ADMET studies, even though interspecies ADME gaps, poor external validity, and high attrition rates are common.
Debarun Patra   +6 more
wiley   +1 more source

Elderly Onset Celiac Disease: A Narrative Review. [PDF]

open access: yes, 2016
Celiac sprue is a chronic disease, which usually occurs in children and young adults. However, it can develop in any age group, and the prevalence is increasing even in the elderly population.
Cappello, M   +2 more
core   +2 more sources

Celiac disease diagnosis and gluten-free food analytical control [PDF]

open access: yes, 2010
Celiac disease (CD) is an autoimmune enteropathy, characterized by an inappropriate T-cell-mediated immune response to the ingestion of certain dietary cereal proteins in genetically susceptible individuals.
Costa-García, Agustín   +5 more
core   +1 more source

Non-celiac gluten sensitivity (NCGS) – an old diagnosis recently rediscovered

open access: yesFamily Medicine & Primary Care Review, 2016
Non-celiac gluten sensitivity (NCGS) is a newly recognised clinical entity by academic medical professionals, but it is better to consider it an old diagnosis recently rediscovered.
Kamil K. Hozyasz
doaj   +1 more source

Home - About - Disclaimer - Privacy